| Photodynamic Therapy of Actinic Keratoses With Alacare® (NCT01571336) | photonamic GmbH & Co. KG | 2012-04-01 |
| A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp (NCT01541553) | LEO Pharma | 2012-03-01 |
| Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis (NCT02248298) | Dong-A University | 2012-01-01 |
| Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis (NCT02278861) | Universidade Federal de Goias | 2011-11-01 |
| Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment (NCT01493921) | G&E Herbal Biotechnology Co., LTD | 2011-10-01 |
| Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (NCT01453179) | MEDA Pharma GmbH & Co. KG | 2011-10-01 |
| PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy (NCT01449513) | LEO Pharma | 2011-09-01 |
| Development and Validation of a Quality of Life Instrument for Actinic Keratosis (NCT01444989) | Wake Forest University | 2011-09-01 |
| Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease (NCT01525329) | The Cleveland Clinic | 2011-09-01 |
| PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology (NCT01387711) | LEO Pharma | 2011-08-01 |
| LAS41005 in Hyperkeratotic Actinic Keratosis (NCT01358851) | Almirall, S.A. | 2011-04-01 |
| Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses (NCT01481155) | Ruhr University of Bochum | 2011-03-01 |
| PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects (NCT01302925) | Peplin | 2011-02-01 |
| Cryosurgery and Cream Combination for Actinic Keratosis (NCT03037541) | Wake Forest University Health Sciences | 2011-01-05 |
| Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis (NCT01265602) | Almirall, S.A. | 2010-11-01 |
| Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment (NCT01459393) | Barretos Cancer Hospital | 2010-11-01 |
| Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (NCT01229319) | Frankel, Amylynne, M.D. | 2010-10-01 |
| Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy (NCT01203878) | Tennessee Clinical Research Center | 2010-09-01 |
| 5fluorouracil for Advanced Photoaging (NCT01405144) | Federal University of São Paulo | 2010-08-01 |
| Photodynamic Treatment of Actinic Keratoses With Different Light Doses (NCT01541228) | Lithuanian University of Health Sciences | 2010-04-01 |
| Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT) (NCT01000636) | Galderma R&D | 2009-10-01 |
| A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study (NCT00989313) | Peplin | 2009-09-01 |
| Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis (NCT00991861) | Almirall, S.A. | 2009-08-01 |
| A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies (NCT00953732) | Peplin | 2009-08-01 |
| A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study (NCT00952783) | Peplin | 2009-07-01 |
| A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) (NCT00917306) | Peplin | 2009-06-01 |
| A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) (NCT00916006) | Peplin | 2009-06-01 |
| A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) (NCT00915551) | Peplin | 2009-06-01 |
| Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery (NCT00894647) | Graceway Pharmaceuticals, LLC | 2009-05-01 |
| A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis (NCT00852137) | Peplin | 2009-03-01 |
| A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers (NCT00850811) | Peplin | 2009-02-01 |
| A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers (NCT00850681) | Peplin | 2009-02-01 |
| Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin (NCT00843323) | University of Sao Paulo | 2008-12-01 |
| A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) (NCT00700063) | Peplin | 2008-06-01 |
| Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis (NCT00987246) | Almirall, S.A. | 2008-06-01 |
| Bioequivalence Study of Two Imiquimod Cream 5% (NCT00828568) | Sun Pharmaceutical Industries, Inc. | 2008-06-01 |
| Imiquimod and Actinic Keratoses: an Observational Study (NCT01151956) | Federal University Teaching Hospital, Feldkirch, Austria | 2008-05-01 |
| Potential Research Study Participant Registry (NCT00710489) | University of California, Davis | 2008-05-01 |
| Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy (NCT02799069) | Biofrontera Bioscience GmbH | 2008-04-01 |
| Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 (NCT00659893) | Peplin | 2008-04-01 |
| A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis (NCT00859105) | Apotex Inc. | 2008-02-01 |
| Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) (NCT00603798) | Graceway Pharmaceuticals, LLC | 2008-01-01 |
| Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis. (NCT02799082) | Biofrontera Bioscience GmbH | 2007-12-01 |
| Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis (NCT02085395) | G&E Herbal Biotechnology Co., LTD | 2007-11-01 |
| Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses (NCT00814528) | University of Chicago | 2007-11-01 |
| A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand (NCT00544297) | Peplin | 2007-10-01 |
| Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp (NCT00306800) | Galderma R&D | 2007-09-01 |
| Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population (NCT00696488) | Wake Forest University | 2007-04-01 |
| Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy (NCT00695578) | Wake Forest University | 2006-10-01 |
| A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis (NCT02799030) | Biofrontera Bioscience GmbH | 2006-10-01 |
| Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses (NCT00375739) | Peplin | 2006-09-01 |
| Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp (NCT00304239) | Galderma R&D | 2006-03-13 |
| Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK (NCT00308854) | photonamic GmbH & Co. KG | 2006-03-01 |
| PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK (NCT00308867) | photonamic GmbH & Co. KG | 2006-03-01 |
| Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions (NCT00294320) | MEDA Pharma GmbH & Co. KG | 2006-02-01 |
| Effect of IDEA-070 on Pain and Inflammation Induced by PDT (NCT00269074) | IDEA AG | 2006-01-01 |
| Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses (NCT00110682) | Derm Research @ 888 Inc. | 2005-04-01 |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses (NCT00107965) | Peplin | 2005-03-01 |
| T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant (NCT00089180) | National Cancer Institute (NCI) | 2004-03-01 |
| Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer (NCT00472459) | Galderma R&D | 2003-07-25 |
| Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream (NCT00335179) | Graceway Pharmaceuticals, LLC | 2003-01-01 |
| A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients (NCT00189267) | MEDA Pharma GmbH & Co. KG | 2002-11-01 |
| Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head (NCT01611480) | Moberg Pharma AB | |